日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Thioquinazolinones as Antituberculosis Agents Targeting Phosphopantetheinyl Transferase

硫代喹唑啉酮类化合物作为靶向磷酸泛酰巯基转移酶的抗结核药物

Singh, Amrita; Zwerneman, Logan T; Planck, Kyle; Kaneko, Takushi; Perkowski, Andrew J; Suh, Christine M; Alex, Alexander; Bean, James; Burns-Huang, Kristin; Zhang, David; Boshoff, Helena I M; Roubert, Christine; Krieger, Inna; Gardner, Mark; Cautain, Bastien; Cooper, Christopher B; Tanvir, Zaid; Sacchettini, James; Gold, Ben S; Rhee, Kyu Y; Fotouhi, Nader; Nathan, Carl F; Aubé, Jeffrey

An Engineered Prodrug Selectively Suppresses β-Lactam-Resistant Bacteria in a Mixed Microbial Setting

一种工程化前药可在混合微生物环境中选择性抑制β-内酰胺类耐药菌。

Duda, Addison M; Ma, Helena R; Villalobos, César A; Kuhn, Sophia A; Angle, Sarah S; He, Katherine; Jackson, Abigail C; Suh, Christine M; Puccio, Elena A; Anderson, Deverick J; Fowler, Vance G; You, Lingchong; Franz, Katherine J

Redirecting raltitrexed from cancer cell thymidylate synthase to Mycobacterium tuberculosis phosphopantetheinyl transferase.

将 raltitrexed 从癌细胞胸苷酸合成酶重定向到结核分枝杆菌磷酸泛酰巯基转移酶

Singh Amrita, Ottavi Samantha, Krieger Inna, Planck Kyle, Perkowski Andrew, Kaneko Takushi, Davis Andrew M, Suh Christine, Zhang David, Goullieux Laurent, Alex Alexander, Roubert Christine, Gardner Mark, Preston Marian, Smith Dave M, Ling Yan, Roberts Julia, Cautain Bastien, Upton Anna, Cooper Christopher B, Serbina Natalya, Tanvir Zaid, Mosior John, Ouerfelli Ouathek, Yang Guangli, Gold Ben S, Rhee Kyu Y, Sacchettini James C, Fotouhi Nader, Aubé Jeffrey, Nathan Carl

An engineered prodrug selectively suppresses β-lactam resistant bacteria in a mixed microbial setting

一种经过基因工程改造的前药能够选择性地抑制混合微生物环境中的β-内酰胺类耐药菌。

Duda, Addison M; Ma, Helena R; Villalobos, César A; Kuhn, Sophia A; He, Katherine; Seay, Sarah R; Jackson, Abigail C; Suh, Christine M; Puccio, Elena A; Anderson, Deverick J; Fowler, Vance G Jr; You, Lingchong; Franz, Katherine J